Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Murray

Showing results (161-170 of 181) with videos related to

Pageof 19
Sort By:
Health Technology Assessment (Winchester, England)|May 12, 2026
Early stroke specialist vocational rehabilitation for REturn To work After stroKE: a synopsis from the RETAKE RCTKate Radford, Alexandra Wright-Hughes, David Clarke, et al.
Journal of Medicinal Chemistry|September 19, 2012
Spirocyclic sulfamides as β-secretase 1 (BACE-1) inhibitors for the treatment of Alzheimer's disease: utilization of structure based drug design, WaterMap, and CNS penetration studies to identify centrally efficacious inhibitorsMichael A Brodney, Gabriela Barreiro, Kevin Ogilvie, et al.
Bone Marrow Transplantation|June 10, 2020
Correction: The challenge of COVID-19 and hematopoietic cell transplantation: EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapyPer Ljungman, Malgorzata Mikulska, Rafael de la Camara, et al.
Journal of Medicinal Chemistry|January 23, 2016
Discovery of Narrow Spectrum Kinase Inhibitors: New Therapeutic Agents for the Treatment of COPD and Steroid-Resistant AsthmaStuart T Onions, Kazuhiro Ito, Catherine E Charron, et al.
Bone Marrow Transplantation|May 15, 2020
The challenge of COVID-19 and hematopoietic cell transplantation; EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapyPer Ljungman, Malgorzata Mikulska, Rafael de la Camara, et al.
Bone Marrow Transplantation|June 18, 2024
Patient engagement in hematopoietic stem cell transplantation and cell therapy: a survey by the EBMT patient engagement task force & transplantation complications working partyHélène Schoemans, Linda J Burns, Sarah J Liptrott, et al.
BMJ Open|March 16, 2022
RETurn to work After stroKE (RETAKE) Trial: protocol for a mixed-methods process evaluation using normalisation process theoryKathryn A Radford, Christopher McKevitt, Sara Clarke, et al.
The European Respiratory Journal|March 14, 2024
ERS/EBMT clinical practice guidelines on treatment of pulmonary chronic graft-<i>versus</i>-host disease in adultsSaskia Bos, John Murray, Monia Marchetti, et al.
American Journal of Respiratory and Critical Care Medicine|February 10, 2007
The safety and efficacy of infliximab in moderate to severe chronic obstructive pulmonary diseaseStephen I Rennard, Charles Fogarty, Steven Kelsen, et al.
Schizophrenia Bulletin|August 23, 2021
Dopamine D1R Receptor Stimulation as a Mechanistic Pro-cognitive Target for SchizophreniaAnissa Abi-Dargham, Jonathan A Javitch, Mark Slifstein, et al.
Pageof 19

Showing results (161-170 of 181) with videos related to

Sort By:
Pageof 19
Health Technology Assessment (Winchester, England)|May 12, 2026
Early stroke specialist vocational rehabilitation for REturn To work After stroKE: a synopsis from the RETAKE RCTKate Radford, Alexandra Wright-Hughes, David Clarke, et al.
Journal of Medicinal Chemistry|September 19, 2012
Spirocyclic sulfamides as β-secretase 1 (BACE-1) inhibitors for the treatment of Alzheimer's disease: utilization of structure based drug design, WaterMap, and CNS penetration studies to identify centrally efficacious inhibitorsMichael A Brodney, Gabriela Barreiro, Kevin Ogilvie, et al.
Bone Marrow Transplantation|June 10, 2020
Correction: The challenge of COVID-19 and hematopoietic cell transplantation: EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapyPer Ljungman, Malgorzata Mikulska, Rafael de la Camara, et al.
Journal of Medicinal Chemistry|January 23, 2016
Discovery of Narrow Spectrum Kinase Inhibitors: New Therapeutic Agents for the Treatment of COPD and Steroid-Resistant AsthmaStuart T Onions, Kazuhiro Ito, Catherine E Charron, et al.
Bone Marrow Transplantation|May 15, 2020
The challenge of COVID-19 and hematopoietic cell transplantation; EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapyPer Ljungman, Malgorzata Mikulska, Rafael de la Camara, et al.
Bone Marrow Transplantation|June 18, 2024
Patient engagement in hematopoietic stem cell transplantation and cell therapy: a survey by the EBMT patient engagement task force & transplantation complications working partyHélène Schoemans, Linda J Burns, Sarah J Liptrott, et al.
BMJ Open|March 16, 2022
RETurn to work After stroKE (RETAKE) Trial: protocol for a mixed-methods process evaluation using normalisation process theoryKathryn A Radford, Christopher McKevitt, Sara Clarke, et al.
The European Respiratory Journal|March 14, 2024
ERS/EBMT clinical practice guidelines on treatment of pulmonary chronic graft-<i>versus</i>-host disease in adultsSaskia Bos, John Murray, Monia Marchetti, et al.
American Journal of Respiratory and Critical Care Medicine|February 10, 2007
The safety and efficacy of infliximab in moderate to severe chronic obstructive pulmonary diseaseStephen I Rennard, Charles Fogarty, Steven Kelsen, et al.
Schizophrenia Bulletin|August 23, 2021
Dopamine D1R Receptor Stimulation as a Mechanistic Pro-cognitive Target for SchizophreniaAnissa Abi-Dargham, Jonathan A Javitch, Mark Slifstein, et al.
Pageof 19